Biodesix and Addario Lung Cancer Medical Institute initiate study to predict overall survival using checkpoint immunotherapy for lung cancer patients

Biodesix and Addario Lung Cancer Medical Institute initiate study to predict overall survival using checkpoint immunotherapy for lung cancer patients

BOULDER and SAN CARLOS, Calif. -- Addario Lung Cancer Medical Institute (ALCMI) and Biodesix, Inc. today announced they will begin an observational study to prospectively evaluate the clinical... Read More

Tuesday September 1, 2020 0 comments Tags: Boulder, Biodesix, Addario Lung Cancer Medical Institute, Scott Hutton

Biodesix to provide COVID-19 testing for CSU campus

Biodesix to provide COVID-19 testing for CSU campus

BOULDER -- Biodesix, Inc. announced it will provide COVID-19 ddPCR diagnostic testing for Colorado State University as students return to campus for the fall term, which begins Aug. 24. “The... Read More

Thursday August 13, 2020 0 comments Tags: Boulder, Biodesix, CSU, COVID-19, Scott Hutton

Biodesix appoints Franchi, Massarany to company's board of directors

Biodesix appoints Franchi, Massarany to company's board of directors

BOULDER -- Biodesix, Inc. announced the appointment of Jean Franchi and Hany Massarany to the company’s board of directors. Ms. Franchi has more than 30 years of biotechnology and life... Read More

Wednesday July 22, 2020 0 comments Tags: Boulder, Biodesix, Jean Franchi, Hany Massarany, Scott Hutton

Biodesix pipeline test identifies patients likely to respond to immune checkpoint inhibitors

Biodesix pipeline test identifies patients likely to respond to immune checkpoint inhibitors

BOULDER -- Biodesix, Inc. announced publication of research findings on a diagnostic test capable of generating valuable data to help guide the treatment of patients with advanced non-small cell... Read More

Monday July 20, 2020 0 comments Tags: Boulder, Biodesix, Scott Hutton

Biodesix collaborates with Bio-Rad to launch test to detect COVID-19 antibodies

Biodesix collaborates with Bio-Rad to launch test to detect COVID-19 antibodies

BOULDER -- Biodesix, Inc . announced it has collaborated with California-based Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) to launch a blood-based immunoassay-based test that identifies... Read More

Wednesday May 20, 2020 0 comments Tags: Boulder, Biodesix, Scott Hutton, COVID-19, Bio-Rad labs

Biodesix begins COVID-19 testing, can process 1,000 tests per day in Boulder

Biodesix begins COVID-19 testing, can process 1,000 tests per day in Boulder

BOULDER -- Biodesix, Inc. announced it began SARS-CoV-2 Droplet Digital PCR (ddPCR) testing for the virus that causes COVID-19 and will immediately submit for Emergency Use Authorization from the... Read More

Wednesday April 8, 2020 0 comments Tags: Boulder, Biodesix, COVID-19, Scott Hutton

Biodesix strengthens lung nodule testing strategy with Nodify CDT test

Biodesix strengthens lung nodule testing strategy with Nodify CDT test

BOULDER -- Biodesix, Inc. announced it is extending its blood-based testing portfolio with the release of the Nodify CDT TM test, designed to help physicians identify patients with lung nodules at... Read More

Wednesday March 4, 2020 0 comments Tags: Boulder, Biodesix, Nodify CDT, Scott Hutton

Biodesix partners with Merck, Pfizer on lung cancer proteomic test

Biodesix partners with Merck, Pfizer on lung cancer proteomic test

BOULDER -- Biodesix, Inc. announced the next phase of the companys biomarker development program with Germany-based Merck and New York-based Pfizer Inc. The companies have completed initial... Read More

Wednesday February 12, 2020 0 comments Tags: Boulder, Biodesix, Scott Hutton